ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Protocol ID
TOTAL 17
Disease (Sub Disease)
Leukaemia
Lymphoma
Diagnosis Stage
Newly diagnosed
Location
VIC
Sponsor
St. Jude Children's Research Hospital
Collaborators
Incyte Corporation
Amgen
Servier
Links
External Registry ≫
Trial Status
Open
Sites
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 2/3
Age Eligibility
1 Year to 18 Years
International registry ID's
NCT03117751
Back to Registry
Study Title Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Protocol ID TOTAL 17
Disease (Sub Disease) Leukaemia
Lymphoma
Diagnosis Stage Newly diagnosed
Location VIC
Sponsor St. Jude Children's Research Hospital
Collaborators Incyte Corporation/ Amgen/ Servier
Links https://clinicaltrials.gov/ct2/show/NCT03117751
Trial Status Open
Trial Open Date 01/12/2021
Sites Royal Children's Hospital
Study Type Treatment
Phase Phase 2/3
Age Eligibility 1 Year to 18 Years
International registry ID's NCT03117751

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.